Should excessive worry be required for a diagnosis of generalized anxiety disorder? Results from the US National Comorbidity Survey Replication

被引:67
作者
Ruscio, AM
Lane, M
Roy-Byrne, P
Stang, PE
Stein, DJ
Wittchen, HU
Kessler, RC
机构
[1] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA
[2] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA
[3] W Chester Univ, Coll Hlth Sci, Galt Associates, W Chester, PA 19380 USA
[4] W Chester Univ, Coll Hlth Sci, Dept Hlth, W Chester, PA 19380 USA
[5] Univ Cape Town, Dept Psychiat, ZA-7925 Cape Town, South Africa
[6] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, D-8027 Dresden, Germany
关键词
D O I
10.1017/S0033291705005908
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background. Excessive worry is required by DSM-IV, but not ICD-10, for a diagnosis of generalized anxiety disorder (GAD). No large-scale epidemiological study has ever examined the implications of this requirement for estimates of prevalence, severity, or correlates of GAD. Method. Data were analyzed from the US National Comorbidity Survey Replication, a nationally representative, face-to-face survey of adults in the USA household population that was fielded in 2001-2003. DSM-IV GAD was assessed with Version 3.0 of the WHO Composite International Diagnostic Interview. Non-excessive worriers meeting all other DSM-IV criteria for GAD were compared with respondents who met full GAD criteria as well as with other survey respondents to consider the implications of removing the excessiveness requirement. Results. The estimated lifetime prevalence of GAD increases by similar to 40% when the excessiveness requirement is removed. Excessive GAD begins earlier in life, has a more chronic course, and is associated with greater symptom severity and psychiatric co-morbidity than non-excessive GAD. However, non-excessive cases nonetheless evidence substantial persistence and impairment of GAD, high rates of treatment-seeking, and significantly elevated co-morbidity compared with respondents without GAD. Non-excessive cases also have sociodemographic characteristics and familial aggregation of GAD comparable to excessive cases. Conclusions. Individuals who meet all criteria for GAD other than excessiveness have a somewhat milder presentation than those with excessive worry, yet resemble excessive worriers in a number of important ways. These findings challenge the validity of the excessiveness requirement and highlight the need for further research into the optimal definition of GAD.
引用
收藏
页码:1761 / 1772
页数:12
相关论文
共 47 条
[1]   GENERALIZABILITY OF DSM-III-R GENERALIZED ANXIETY DISORDERS TO PROPOSED DSM-IV CRITERIA AND CROSS-VALIDATION OF PROPOSED CHANGES [J].
ABEL, JL ;
BORKOVEC, TD .
JOURNAL OF ANXIETY DISORDERS, 1995, 9 (04) :303-315
[2]  
American Psychological Association, 2013, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890425596.744053, DOI 10.1176/APPI.BOOKS.9780890425596.744053, 10.1176/appi.books.9780890425596]
[3]  
ANDREASEN NC, 1977, ARCH GEN PSYCHIAT, V34, P1229
[4]  
[Anonymous], PROF SOFTW SURV DAT
[5]  
Ballenger JC, 2001, J CLIN PSYCHIAT, V62, P53
[6]   DSM-IV and beyond: what is generalized anxiety disorder? [J].
Barlow, DH ;
Wincze, J .
ACTA PSYCHIATRICA SCANDINAVICA, 1998, 98 :23-29
[7]   Characterizing generalized anxiety: Temporal and symptomatic thresholds [J].
Bienvenu, OJ ;
Nestadt, G ;
Eaton, WW .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 1998, 186 (01) :51-56
[8]  
Borkovec T.D., 1994, Worrying: Perspectives on theory, assessment, and treatment, P5, DOI DOI 10.1017/S0033291700036357
[9]  
Borkovec TD., 1991, Chronic anxiety: Generalized anxiety disorder and mixed anxiety-depression, P29
[10]   The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder [J].
Bouffard, R ;
Hechtman, L ;
Minde, K ;
Iaboni-Kassab, F .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2003, 48 (08) :546-554